Callan Family Office’s Target TGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Buy
12,790
+195
+2% +$24.8K 0.03% 445
2026
Q1
$1.53M Sell
12,595
-708
-5% -$79.8K 0.03% 431
2025
Q4
$1.3M Buy
13,303
+3,089
+30% +$285K 0.03% 467
2025
Q3
$916K Sell
10,214
-1,878
-16% -$185K 0.03% 399
2025
Q2
$1.19M Buy
12,092
+5,258
+77% +$505K 0.04% 361
2025
Q1
$713K Sell
6,834
-1,875
-22% -$234K 0.05% 257
2024
Q4
$1.18M Buy
+8,709
New +$1.25M 0.07% 220
2023
Q3
– Sell
-5,143
Closed -$678K – 112
2023
Q2
$678K Buy
5,143
+13
+0.3% +$1.93K 0.18% 54
2023
Q1
$850K Sell
5,130
-28
-0.5% -$4.6K 0.21% 71
2022
Q4
$769K Buy
+5,158
New +$809K 0.25% 42

Other funds holding TGT

Callan Family Office's TGT Position: Q2 2026 in Review

Callan Family Office increased its Target (TGT) stake by 1.5% in Q2 2026, buying an estimated $24.8K and bringing the position to 12,790 shares worth $1.67M. The position accounts for 0.03% of the portfolio, ranked #445.

Callan Family Office first reported a position in TGT in Q4 2022 and has held it in 10 quarters since. 1,897 funds tracked by Wall St. Rank hold TGT as of Q2 2026.

  • Callan Family Office held 12,790 shares of Target worth $1.67M as of Q2 2026.
  • Callan Family Office bought 195 Target shares in Q2 2026, an estimated $24.8K.
  • Target made up 0.03% of Callan Family Office's portfolio in Q2 2026, its #445 holding.
  • Callan Family Office first reported a position in Target in Q4 2022 and has held it in 10 quarters since.
  • 1,897 funds tracked by Wall St. Rank held Target as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.